title: [The first HPV vaccine is now available].
abstract: More than two thirds of carcinomas of the uterine cervix are caused by human papilloma virus (HPV) types 16 and 18, and 90% of all genital warts are caused by HPV 6 and 11. In June 2006, the US Food and Drug Administration accepted the first prophylactic HPV vaccine against HPV 6, 11, 16 and 18 to be offered to girls and young women. This new vaccine is also now available in Denmark. Questions concerning economics, ethics, organization, and vaccine monitoring need to be discussed in connection with the establishment of a vaccine program. In addition, information to the general population as well as to health care providers and decision-makers should have been given a high priority.
authors.affiliation: Juliane Marie Centret, H:S Rigshospitalet, DK-2100 København Ø.
authors.forename: Susanne Krüger
authors.initials: SK
authors.lastname: Kjaer
authors.forename: Frede
authors.initials: F
authors.lastname: Olesen
authors.forename: Kim
authors.initials: K
authors.lastname: Toftager-Larsen
authors.forename: Carsten
authors.initials: C
authors.lastname: Sand
authors.forename: Gitte I
authors.initials: GI
authors.lastname: Strauss
authors.forename: Thomas U
authors.initials: TU
authors.lastname: Hoffmann
authors.forename: Bent S
authors.initials: BS
authors.lastname: Ottesen
mesh_terms: D000293:Adolescent; D002648:Child; D003718:Denmark; D005260:Female; D006801:Humans; D017589:Immunization Programs / Q000191:economics / Q000458:organization & administration; D008297:Male; D030361:Papillomavirus Infections / Q000150:complications / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000600:supply & distribution; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology
chemical_list: D053918:Papillomavirus Vaccines